Duloxetine for the treatment of mood disorder in cancer patients: a 12-week case-control clinical trial.
about
Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.Pharmacological management of depression in patients with cancer: practical considerations.Mental adjustment to cancer: the role of anxious and depressive symptoms under treatment.Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?
P2860
Duloxetine for the treatment of mood disorder in cancer patients: a 12-week case-control clinical trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Duloxetine for the treatment o ...... k case-control clinical trial.
@en
Duloxetine for the treatment o ...... k case-control clinical trial.
@nl
type
label
Duloxetine for the treatment o ...... k case-control clinical trial.
@en
Duloxetine for the treatment o ...... k case-control clinical trial.
@nl
prefLabel
Duloxetine for the treatment o ...... k case-control clinical trial.
@en
Duloxetine for the treatment o ...... k case-control clinical trial.
@nl
P2860
P356
P1476
Duloxetine for the treatment o ...... k case-control clinical trial.
@en
P2093
Riccardo Torta
Roberto Borio
P2860
P304
P356
10.1002/HUP.1202
P577
2011-06-01T00:00:00Z